Results 211 to 220 of about 6,548,876 (337)
A lipopolysaccharide inhibitor of a DNA methyl transferase. [PDF]
A Falaschi, A Kornberg
openalex +1 more source
Non‐small cell lung cancer targeted treatment is limited to a few known genetic alterations, with few alternatives in advanced treatment lines. To direct treatment decisions by drug sensitivity testing (DST), this study compared several methods for tumor cell isolation from malignant effusions, pointing to repeated CD45+ cell depletion for effective ...
Navit Mooshayef+10 more
wiley +1 more source
Tumor irradiation induced immunogenic response: the impact of DNA damage induction and misrepair. [PDF]
Liu Q, Shi X, Tayier N, Ma L.
europepmc +1 more source
Human cytomegalovirus infection is common in normal prostate epithelium, prostate tumor tissue, and prostate cancer cell lines. CMV promotes cell survival, proliferation, and androgen receptor signaling. Anti‐CMV pharmaceutical compounds in clinical use inhibited cell expansion in prostate cancer models in vitro and in vivo, motivating investigation ...
Johanna Classon+13 more
wiley +1 more source
DNA Photofluids: An Innovative Breakthrough in Mimicking Cellular Life Behaviors. [PDF]
Wang R, Cui W, Chen X.
europepmc +1 more source
In luminal (ER+) breast carcinoma (BC), miRNA profiling identified miR‐195‐5p as a key regulator of proliferation that targets CHEK1, CDC25A, and CCNE1. High CHEK1 expression correlates with worse relapse‐free survival after chemotherapy, especially in patients with luminal A subtype.
Veronika Boušková+14 more
wiley +1 more source
3D structure and stability prediction of DNA with multi-way junctions in ionic solutions. [PDF]
Wang X, Shi YZ.
europepmc +1 more source
Diurnal Fluctuations in the Numbers of DNA Synthesizing Nuclei in Various Mouse Tissues [PDF]
Ch. Pilgrim, Walter Erb, W. Maurer
openalex +1 more source
In thyroid cancer patients, high‐dose (≥7.4 GBq) radioactive iodine therapy (RAIT) was associated with a higher prevalence of clonal hematopoiesis (variant allele frequency >2%) in individuals aged ≥50 years (OR = 2.44). In silico analyses showed that truncating PPM1D mutations conferred a selective advantage under these conditions.
Jaeryuk Kim+11 more
wiley +1 more source